Frenchtown Drug | |
16862 Beckwith St, Ste P, Frenchtown, Montana 59834 | |
(406) 626-4113 |
Name | Frenchtown Drug |
---|---|
Organization Name | G & E Ventures Inc |
Location | 16862 Beckwith St, Ste P, Frenchtown, Montana 59834 |
Type | Supplier |
Phone | (406) 626-4113 |
Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.
Researchers have generated protease-activatable fluorescent and luminescent biosensors for SARS-CoV-2 MPro (main protease) and PLPro (papain-like protease) activity, one based on "flip" GFP (FlipGFP), and the other based on circularly permuted firefly luciferase (FFluc).
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
Kapakahines, marine-derived natural products isolated from a South Pacific sponge in trace quantities, have shown anti-leukemia potential, but studies have been all but stalled by kapakahines' lack of availability.
The Vaccine Education Center at The Children's Hospital of Philadelphia is launching Vaccines on the Go: What You Should Know, a unique mobile app that allows busy parents to access up-to-date, reliable information about the science and safety of vaccines - wherever and whenever they need it.
› Verified 9 days ago
News Archive
Millions of people worldwide suffer from a type of chronic pain called neuropathic pain, which is triggered by nerve damage. Precisely how this pain persists has been a mystery, and current treatments are largely ineffective. But a team led by scientists from The Scripps Research Institute, using a new approach known as metabolomics, has now discovered a major clue: dimethylsphingosine (DMS), a small-molecule byproduct of cellular membranes in the nervous system.
Researchers have generated protease-activatable fluorescent and luminescent biosensors for SARS-CoV-2 MPro (main protease) and PLPro (papain-like protease) activity, one based on "flip" GFP (FlipGFP), and the other based on circularly permuted firefly luciferase (FFluc).
ACADIA Pharmaceuticals Inc., a biopharmaceutical company utilizing innovative technology to fuel drug discovery and clinical development of novel treatments for central nervous system disorders, today reported its unaudited financial results for the third quarter ended September 30, 2011.
Kapakahines, marine-derived natural products isolated from a South Pacific sponge in trace quantities, have shown anti-leukemia potential, but studies have been all but stalled by kapakahines' lack of availability.
The Vaccine Education Center at The Children's Hospital of Philadelphia is launching Vaccines on the Go: What You Should Know, a unique mobile app that allows busy parents to access up-to-date, reliable information about the science and safety of vaccines - wherever and whenever they need it.
› Verified 9 days ago
Frenchtown Drug Type: Medicare Supplier Location: 16862 Beckwith St, Frenchtown, Montana 59834 Phone: (406) 626-4113 |